Literature DB >> 33358864

GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH.

Kook Hwan Kim1, Myung-Shik Lee2.   

Abstract

BACKGROUND: Mitochondria is a key organelle for energy production and cellular adaptive response to intracellular and extracellular stresses. Mitochondrial stress can be evoked by various stimuli such as metabolic stressors or pathogen infection, which may lead to expression of 'mitokines' such as growth differentiation factor 15 (GDF15). SCOPE OF REVIEW: This review summarizes the mechanism of GDF15 expression in response to organelle stress such as mitochondrial stress, and covers pathophysiological conditions or diseases that are associated with elevated GDF15 level. This review also illustrates the in vivo role of GDF15 expression in those stress conditions or diseases, and a potential of GDF15 as a therapeutic agent against metabolic disorders such as NASH. MAJOR
CONCLUSIONS: Mitochondrial unfolded protein response (UPRmt) is a critical process to recover from mitochondrial stress. UPRmt can induce expression of secretory proteins that can exert systemic effects (mitokines) as well as mitochondrial chaperons. GDF15 can have either protective or detrimental systemic effects in response to mitochondrial stresses, suggesting its role as a mitokine. Mounting evidence shows that GDF15 is also induced by stresses of organelles other than mitochondria such as endoplasmic reticulum (ER). GDF15 level is increased in serum or tissue of mice and human subjects with metabolic diseases such as obesity or NASH. GDF15 can modulate metabolic features of those diseases. GENERAL SIGNIFICANCE: GDF15 play a role as an integrated stress response (ISR) beyond mitochondrial stress response. GDF15 is involved in the pathogenesis of metabolic diseases such as NASH, and also could be a candidate for therapeutic agent against those diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ER; GDF15; Metabolic diseases; Mitochondria; NASH; Stress

Year:  2020        PMID: 33358864     DOI: 10.1016/j.bbagen.2020.129834

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  8 in total

Review 1.  Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c).

Authors:  Tae Kwan Yoon; Chan Hee Lee; Obin Kwon; Min-Seon Kim
Journal:  Diabetes Metab J       Date:  2022-05-25       Impact factor: 5.893

Review 2.  Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.

Authors:  Darakhshan Sohail Ahmed; Stéphane Isnard; Carolina Berini; John Lin; Jean-Pierre Routy; Léna Royston
Journal:  Front Immunol       Date:  2022-02-16       Impact factor: 7.561

Review 3.  Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases.

Authors:  Qingfei Chu; Xinyu Gu; Qiuxian Zheng; Jing Wang; Haihong Zhu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-11       Impact factor: 2.916

4.  Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.

Authors:  Ying Wang; Chaojie Chen; Jiajun Chen; Tingting Sang; He Peng; Xiaojian Lin; Qian Zhao; Shengjia Chen; Thomas Eling; Xingya Wang
Journal:  Redox Biol       Date:  2022-04-27       Impact factor: 10.787

5.  Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity.

Authors:  Mohamed Asrih; Flore Sinturel; Richard Dubos; Idris Guessous; Zoltan Pataky; Charna Dibner; François R Jornayvaz; Karim Gariani
Journal:  Endocr Connect       Date:  2022-07-12       Impact factor: 3.221

6.  Cell non-autonomous effect of hepatic growth differentiation factor 15 on the thyroid gland.

Authors:  Seonhyang Jeong; Seul Gi Lee; Kook Hwan Kim; Xuguang Zhu; Woo Kyung Lee; Hwa Young Lee; Sunmi Park; Myung-Shik Lee; Sheue-Yann Cheng; Jandee Lee; Young Suk Jo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

Review 7.  Chrono-communication and cardiometabolic health: The intrinsic relationship and therapeutic nutritional promises.

Authors:  Pamela Senesi; Anna Ferrulli; Livio Luzi; Ileana Terruzzi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

8.  Response of Circulating Inflammatory Markers to Intermittent Hypoxia-Hyperoxia Training in Healthy Elderly People and Patients with Mild Cognitive Impairment.

Authors:  Zoya O Serebrovska; Lei Xi; Lesya V Tumanovska; Angela M Shysh; Sergii V Goncharov; Michael Khetsuriani; Taisia O Kozak; Denis A Pashevin; Victor E Dosenko; Sergii V Virko; Viktor A Kholin; Oksana N Grib; Natalie A Utko; Egor Egorov; Anna O Polischuk; Tetiana V Serebrovska
Journal:  Life (Basel)       Date:  2022-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.